Positioning Imatinib for Pulmonary Arterial Hypertension
Condition(s):Pulmonary Arterial HypertensionLast Updated:October 10, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Pulmonary Arterial HypertensionLast Updated:October 10, 2023Active, not recruiting
Condition(s):Pulmonary Arterial HypertensionLast Updated:August 31, 2016Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:August 5, 2022Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:April 25, 2022Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:May 21, 2019Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:May 4, 2021Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:May 20, 2022Recruiting
Condition(s):Pulmonary Arterial HypertensionLast Updated:September 24, 2020Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:March 27, 2024Recruiting
Condition(s):Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)Last Updated:March 28, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.